Development of chimeric antigen receptors targeting the γδ T cell receptor
Lauren C Cutmore, Norris Lam, Christina Amatya, Katherine A Weissler, Stephen M Hewitt, Danielle A Natrakul, James N Kochenderfer · 2026
Read Development of chimeric antigen receptors targeting the γδ T cell receptor by Lauren C Cutmore, Norris Lam, Christina Amatya, Katherine A Weissler, Stephen M Hewitt, Danielle A Natrakul, James N Kochenderfer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13310624.txt.
Description
Lauren C Cutmore and colleagues engineer immune cells in 2026 to hunt cancers arising from gamma-delta T cells, a rare T cell class with no approved targeted treatment. The team built chimeric antigen receptors aimed at the gamma-delta receptor itself, varying the targeting fragment, hinge, and costimulatory parts. Candidate receptors were screened by cytokine release against receptor-bearing target cells.
Two targeting fragments showed clean specificity, and one design, labelled MGDL, transferred into T cells most efficiently. Among three MGDL versions, the one using CD28 parts released the most cytokine on target contact. In two mouse models of gamma-delta leukaemia, that version gave the strongest anti-leukaemia activity and the longest survival. Cancers of this type, including hepatosplenic lymphoma, carry grim outlooks with median survival sometimes under a year. The authors support moving the winning design into a clinical trial.
Catalog record
| CREATOR | Lauren C Cutmore, Norris Lam, Christina Amatya, Katherine A Weissler, Stephen M Hewitt, Danielle A Natrakul, James N Kochenderfer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |